The U.S. stands on the verge of adding a second vaccine to its arsenal as the coronavirus outbreak descends deeper into its most lethal phase yet. The Food and Drug Administration is evaluating a shot developed by Moderna Inc., and a decision could clear the way for its use as early as Monday.